Our driving ambition is to be at the forefront of drug and medical device development.Georg DorffnerFounder of The Siesta Group
Our Identity
— The Accomplished Pioneer
20 years of Commitment
With over two decades of groundbreaking innovation pioneering the field of computer- assisted sleep scoring and EEG biomarker extraction, The Siesta Group is setting the benchmark in measuring, analyzing, and interpreting bio-signals.
Global Network
From our headquarters in Europe, we have worked with some of the most prominent pharmaceutical and biotechnology firms across the globe e.g. Johnson & Johnson, Eli Lilly, Eisai, Roche, Merck, Takeda.
Continuous Growth
We have supported 100+ clinical trials, making us a key player in the development of cutting- edge neurology therapies. We have analyzed more than 100 000 PSG and EEG recordings and published over 80 articles in peer- reviewed scientific journals.
Our driving ambition is to be at the forefront of drug and medical device development.Our Mission
Maximum quality in end-to-end solutions combining quality-controlled data acquisition, benchmark central scoring and cutting-edge
AI-powered biomarker analysis.
From Biosignal to Biomarker
Disease-specific biomarker research
Upgrade your CNS Trial
Unparalleled insights through proprietary analysis tools and visualization
Device Agnostic
Recommending most fit-for-purpose solution
Our Partners
Biotechs & Pharma 
CROs
Devices
Phase 1 Units
Institutions
Scientific Societies